Deglycosylated bleomycin triggers apoptosis in laryngeal carcinoma cells in a caspase and reactive oxygen species independent manner

Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Souhir BrahimAbderraouf Kenani

Abstract

Bleomycin-A2, a member of a family of glycopeptide antibiotics, has potent antitumor activity against a range of lymphomas, head and neck cancer and germ cell tumors. However, little is known about the biologic activity of the carbohydrate moiety in Bleomycin-A2-induced cytotoxicity. We compared the capacity of Bleomycin-A2 and its deglycosylated form (deglycoBleomycin-A2) to induce cell death. Apoptosis was analyzed by cell nuclear staining with Hoechst 33342 dye and DNA fragmentation. The signal transduction pathway was measured through Western blotting and production of reactive oxygen species (ROS). When tested on HEp-2 laryngeal carcinoma cells, Bleomycin-A2, and deglycoBleomycin-A2 decreased cell viability and clonogenic survival, but Bleomycin-A2 was more toxic than its deglycosylated form. The cell death occurred by apoptosis as identified by condensed chromatin and the formation of apoptotic bodies. While Bleomycin-A2-induced apoptosis was dependent on caspase activation and ROS production, deglycoBleomycin-A2-triggered apoptosis did not require caspase activation and ROS production. The deglycosylation of Bleomycin-A2 suppresses the ability of the drug to induce ROS formation without hampering its toxic effect. These ...Continue Reading

References

Dec 1, 1969·The Journal of Urology·T IchikawaI Hirokawa
Jun 1, 1970·The Journal of Antibiotics·T Terasima, H Umezawa
Feb 1, 1980·The American Journal of Medicine·R B Weiss, F M Muggia
Nov 1, 1994·Current Opinion in Oncology·S J Martin, D R Green
Oct 18, 1996·Cell·E S AlnemriJ Yuan
Jan 1, 1997·American Journal of Respiratory Cell and Molecular Biology·N HagimotoN Hara
Mar 11, 1997·Biochemistry·T E LehmannL Que
Oct 6, 1997·American Journal of Respiratory Cell and Molecular Biology·N HagimotoN Hara
Jul 11, 1998·Respiratory Medicine·A Gillissen, D Nowak
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Jul 13, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·R WangB D Uhal
Feb 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·K KuwanoN Hara
Feb 19, 2002·Chemical Reviews·Richard M. Burger
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David B DugganBruce A Peterson
Nov 26, 2003·Cellular Signalling·Andrew Thorburn
Dec 4, 2003·Free Radical Biology & Medicine·Daniela CaporossiMaria Giulia Farace
Dec 4, 2003·Current Opinion in Cell Biology·Kelly M Boatright, Guy S Salvesen
Dec 10, 2003·The Lancet Oncology·Wei Hu, John J Kavanagh
Sep 9, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Vivian Y LeeNavdeep S Chandel

❮ Previous
Next ❯

Citations

Feb 19, 2016·Science Translational Medicine·Olivier BurgyPhilippe Bonniaud
Dec 2, 2010·Natural Product Reports·Barbara La FerlaFrancesco Nicotra
Jun 8, 2018·Applied Microbiology and Biotechnology·Jieqian KongXiangcheng Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis